Insulet
PODD
#1348
Rank
HK$127.17 B
Marketcap
HK$1,807
Share price
2.60%
Change (1 day)
-11.13%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2025 (TTM): HK$27.23

According to Insulet's latest financial reports the company's current EPS (TTM) is HK$27.43. In 2024 the company made an earnings per share (EPS) of HK$46.87 an increase over its 2023 EPS that were of HK$23.12.

EPS history for Insulet from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$27.23-41.9%
2024HK$46.87102.71%
2023HK$23.124114.29%
2022HK$0.55-69.57%
2021HK$1.80109.09%
2020HK$0.86-38.89%
2019HK$1.41200%
2018HK$0.47-113.04%
2017-HK$3.61-9.8%
2016-HK$4.00-60.47%
2015-HK$10.1138.71%
2014-HK$7.2912.05%
2013-HK$6.51-23.15%
2012-HK$8.47-12.2%
2011-HK$9.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.29 218.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.38 7.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$29.08 6.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$180.43 557.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$23.91-187.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
-HK$2.43-108.86%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$14.50-47.14%๐Ÿ‡บ๐Ÿ‡ธ USA